Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -3.62%3.62B | -2.99%3.76B | 4.90%3.88B | 3.62%3.69B | -0.64%3.57B | 1.99%3.59B | -1.98%3.52B | 4.51%3.59B | 2.63%3.43B | -0.09%3.35B |
| Operating revenue | -3.62%3.62B | -2.99%3.76B | 4.90%3.88B | 3.62%3.69B | -0.64%3.57B | 1.99%3.59B | -1.98%3.52B | 4.51%3.59B | 2.63%3.43B | -0.09%3.35B |
| Cost of revenue | -0.71%1.81B | -2.41%1.82B | 6.14%1.87B | 4.95%1.76B | 0.84%1.68B | 2.28%1.66B | 2,520.97%1.63B | 3.33%62M | -13.04%60M | 40.82%69M |
| Gross profit | -6.35%1.81B | -3.54%1.94B | 3.77%2.01B | 2.44%1.94B | -1.92%1.89B | 1.74%1.93B | -46.33%1.89B | 4.53%3.53B | 2.96%3.37B | -0.70%3.28B |
| Operating expense | 5.44%1.45B | -0.29%1.38B | 3.99%1.38B | 1.14%1.33B | 1.23%1.31B | 0.46%1.3B | -56.82%1.29B | 1.01%2.99B | 3.06%2.96B | -3.23%2.87B |
| Selling and administrative expenses | -12.24%581M | 1.85%662M | 4.84%650M | -1.59%620M | -3.37%630M | 3.66%652M | -10.40%629M | -2.23%702M | 7.81%718M | -3.20%666M |
| -Selling and marketing expense | 7.41%58M | -3.57%54M | -6.67%56M | -16.67%60M | -7.69%72M | -10.34%78M | 3.57%87M | 21.74%84M | -10.39%69M | -1.28%77M |
| -General and administrative expense | -13.98%523M | 2.36%608M | 6.07%594M | 0.36%560M | -2.79%558M | 5.90%574M | -12.30%542M | -4.78%618M | 10.19%649M | -3.44%589M |
| Depreciation amortization depletion | 17.53%590M | 4.58%502M | -7.69%480M | -0.57%520M | 15.71%523M | -5.24%452M | 9.91%477M | 0.93%434M | -3.59%430M | -1.55%446M |
| -Depreciation and amortization | 17.53%590M | 4.58%502M | -7.69%480M | -0.57%520M | 15.71%523M | -5.24%452M | 9.91%477M | 0.93%434M | -3.59%430M | -1.55%446M |
| Provision for doubtful accounts | 26.67%19M | 66.67%15M | 125.00%9M | 157.14%4M | -141.18%-7M | 41.67%17M | -25.00%12M | -11.11%16M | -18.18%18M | 69.23%22M |
| Other operating expenses | 32.16%263M | -18.11%199M | 31.35%243M | 10.12%185M | -5.08%168M | 1.72%177M | -90.54%174M | 2.45%1.84B | 3.22%1.8B | -4.19%1.74B |
| Operating profit | -35.42%361M | -10.70%559M | 3.30%626M | 5.39%606M | -8.44%575M | 4.49%628M | 12.34%601M | 29.85%535M | 2.23%412M | 22.12%403M |
| Net non-operating interest income (expenses) | -15.69%-118M | -52.24%-102M | -39.58%-67M | -2.13%-48M | 18.97%-47M | -20.83%-58M | -54.84%-48M | -14.81%-31M | 10.00%-27M | 0.00%-30M |
| Non-operating interest income | -26.19%31M | 31.25%42M | 23.08%32M | -23.53%26M | -5.56%34M | -2.70%36M | 146.67%37M | 0.00%15M | -6.25%15M | -33.33%16M |
| Non-operating interest expense | 11.36%98M | 66.04%88M | 10.42%53M | 2.13%48M | -17.54%47M | 11.76%57M | 10.87%51M | 9.52%46M | -8.70%42M | -14.81%46M |
| Total other finance cost | -8.93%51M | 21.74%56M | 76.92%46M | -23.53%26M | -8.11%34M | 8.82%37M | --34M | ---- | ---- | ---- |
| Other net income (expenses) | 17.07%96M | -86.71%82M | 2,582.61%617M | -8.00%23M | -26.47%25M | 41.67%34M | 0.00%24M | -86.21%24M | 27.01%174M | -23.46%137M |
| Special income (charges) | -86.67%8M | 200.00%60M | 150.00%20M | 14.29%8M | -73.08%7M | 966.67%26M | 90.91%-3M | -1,550.00%-33M | 77.78%-2M | ---9M |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --26M | ---- | ---- |
| -Less:Impairment of capital assets | ---- | --2M | ---- | 0.00%2M | 0.00%2M | -33.33%2M | -57.14%3M | 250.00%7M | -77.78%2M | --9M |
| -Gain on sale of property,plant,equipment | -87.10%8M | 210.00%62M | 100.00%20M | 11.11%10M | -67.86%9M | --28M | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 141.03%94M | -93.46%39M | 3,625.00%596M | -15.79%16M | 171.43%19M | -75.00%7M | -53.33%28M | -66.67%60M | 19.21%180M | -17.03%151M |
| Income before tax | -32.49%347M | -55.38%514M | 98.28%1.15B | 5.06%581M | -4.16%553M | -0.35%577M | 10.29%579M | -6.25%525M | 9.38%560M | 6.22%512M |
| Income tax | -52.02%95M | 1,064.71%198M | -90.06%17M | 1.18%171M | 12.67%169M | -11.76%150M | 21.43%170M | -1.41%140M | 0.00%142M | 32.71%142M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -17.72%260M | -72.16%316M | 176.83%1.14B | 6.77%410M | -10.07%384M | 4.40%427M | 6.23%409M | -7.89%385M | 12.97%418M | -1.33%370M |
| Net income continuous operations | -20.25%252M | -72.16%316M | 176.83%1.14B | 6.77%410M | -10.07%384M | 4.40%427M | 6.23%409M | -7.89%385M | 12.97%418M | -1.33%370M |
| Net income discontinuous operations | --8M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -17.72%260M | -72.16%316M | 176.83%1.14B | 6.77%410M | -10.07%384M | 4.40%427M | 6.23%409M | -7.89%385M | 12.97%418M | -0.80%370M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -17.72%260M | -72.16%316M | 176.83%1.14B | 6.77%410M | -10.07%384M | 4.40%427M | 6.23%409M | -7.89%385M | 12.97%418M | -0.80%370M |
| Diluted earnings per share | -18.61%0.1408 | -71.50%0.173 | 177.17%0.607 | 5.80%0.219 | -10.78%0.207 | 4.04%0.232 | 6.19%0.223 | -7.89%0.21 | 12.87%0.228 | 1.00%0.202 |
| Basic earnings per share | -18.61%0.1408 | -71.45%0.173 | 176.71%0.606 | 5.80%0.219 | -10.78%0.207 | 4.04%0.232 | 6.19%0.223 | -7.89%0.21 | 12.87%0.228 | 1.00%0.202 |
| Dividend per share | -2.95%0.2606 | 3.67%0.2685 | -5.18%0.259 | 0.41%0.2731 | 7.11%0.272 | 3.48%0.2539 | 0.95%0.2454 | -4.67%0.2431 | -0.45%0.255 | 43.46%0.2561 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |